Martin Gerstel

Portfolio · 1

Itamar Medical

Home Sleep Testing and Endothelial Function Assessment

3 rounds $31.3M committed Latest: 2005-10

Investment activity

1 portfolio exit on record.

Q&A

What is Martin Gerstel's primary investment focus by sector?

Martin Gerstel primarily focuses on the Health Tech & Life Sciences sector, with all of his recorded portfolio companies and exits in this area.

Can you name a notable exit for Martin Gerstel?

A notable exit for Martin Gerstel is Itamar Medical, which went public on the TASE in February 2007.

What is a key portfolio company for Martin Gerstel?

A key portfolio company for Martin Gerstel is Itamar Medical, a company founded in 1997 that focuses on home sleep testing and endothelial function assessment.

What is Martin Gerstel's typical investment range?

Martin Gerstel's typical investment range is between $8M and $12M.

When did Martin Gerstel make his most recent recorded investment?

Martin Gerstel's most recent recorded investment was in October 2005.

What funding stages has Martin Gerstel participated in?

Martin Gerstel has participated in B Round and C Round funding stages.